Amgen, Inc. (NASDAQ:AMGN)

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, April 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Boeing, P&G and 5 More Key Earnings Reports Coming Wednesday

The U.S. broad markets posted a handy gain on Tuesday following a series of strong earnings reports. This was also a record session for the Nasdaq with the index hitting ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, March 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Interest Pulls Back in Major Biotechs

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs See a Retreat in Short Interest

The short interest data are out for the most recent settlement date, February 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Stocks were indicated lower on Thursday ahead of Friday's key payrolls and unemployment report. The European Central Bank maintained rates at 0.00%. Now that the bull market is officially eight years ...
Read Full Story »
biotech word cloud

Short Sellers Hike Their Bets in Major Biotechs

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
automatic inspection machine

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Almost every asset class is overbought now, and the few that aren’t — with the exception of one — have good reasons. Utilities and other income proxy stocks that were big in ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Broadcom, Canadian Solar, Goldman Sachs, TripAdvisor, Wal-Mart and More

Stocks were indicated lower on Wednesday after hitting higher highs. Maybe eight days of rallying is too much at one time and the Dow is now close enough to 21,000 ...
Read Full Story »
Wow

Major Biotechs Scare Off Loads of Short Sellers

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
thumbs up

Why Amgen Earnings Are So Incredible

Amgen Inc. (NASDAQ: AMGN) reported fourth-quarter financial results after markets closed on Thursday. This biotech giant posted $2.89 in earnings per share (EPS) and $5.97 billion in revenue, versus consensus ...
Read Full Story »
hundred dollar bill

Top 6 Earnings To Watch For On Thursday

Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems the animal spirits powering this rally might not be as ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Amgen, Apple, Corning, Mobileye, Under Armour, Electronic Arts and Many More

Stocks started the week off on a weak note with a handy drop, but a much stronger than expected ADP payrolls report is driving stocks higher on Wednesday. Despite this ...
Read Full Story »
biotech word cloud

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, January 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with ...
Read Full Story »
research

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

While the run since the Trump election and now the inauguration has been solid, there are some storm clouds on the horizon. Volatility has drifted to historic lows, while price-to-earnings ...
Read Full Story »